Guidance for U.S. laboratories testing for Zika virus infection
Published Date:July 26, 2016
Corporate Authors:Centers for Disease Control and Prevention (U.S.)
Description:Overview -- Specimen Referral -- Specimen Type -- Use of CDC Assays by Qualified Laboratories -- Biological Safety -- Methods: Molecular testing; Antibody detection methods -- Reporting -- References -- 2016 Zika Response: Algorithm for U.S. Testing of Symptomatic Individuals -- 2016 Zika Response: Algorithm for U.S. Testing of Symptomatic Individuals -- 2016 Zika Response: Algorithm for U.S. Testing of Asymptomatic Pregnant Women.
Testing of specimens within the United States to determine possible Zika virus infection should be limited to specimens collected from patients meeting CDC’s clinical and epidemiological criteria for testing1. Clinical signs and symptoms associated with Zika virus infection are discussed here: http://www.cdc.gov/zika/symptoms/index.html. It is important to note that Zika virus infection can cause signs and symptoms similar to those seen in patients with dengue and chikungunya virus infections.
Current information and guidance for the U.S. Zika response is available on CDC’s Zika website: http://www.cdc.gov/zika/index.html. Information specific to state and public health laboratory response: http://www.cdc.gov/zika/laboratories/index.html.
Full testing algorithms are presented at the end of this document.
Supporting Files:No Additional Files
You May Also Like: